1. Home
  2. COHU vs DVAX Comparison

COHU vs DVAX Comparison

Compare COHU & DVAX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • COHU
  • DVAX
  • Stock Information
  • Founded
  • COHU 1947
  • DVAX 1996
  • Country
  • COHU United States
  • DVAX United States
  • Employees
  • COHU N/A
  • DVAX N/A
  • Industry
  • COHU Electrical Products
  • DVAX Biotechnology: Pharmaceutical Preparations
  • Sector
  • COHU Industrials
  • DVAX Health Care
  • Exchange
  • COHU Nasdaq
  • DVAX Nasdaq
  • Market Cap
  • COHU 1.3B
  • DVAX 1.5B
  • IPO Year
  • COHU N/A
  • DVAX 2004
  • Fundamental
  • Price
  • COHU $24.99
  • DVAX $12.21
  • Analyst Decision
  • COHU Buy
  • DVAX Buy
  • Analyst Count
  • COHU 6
  • DVAX 2
  • Target Price
  • COHU $31.50
  • DVAX $22.00
  • AVG Volume (30 Days)
  • COHU 344.5K
  • DVAX 3.3M
  • Earning Date
  • COHU 10-31-2024
  • DVAX 11-07-2024
  • Dividend Yield
  • COHU N/A
  • DVAX N/A
  • EPS Growth
  • COHU N/A
  • DVAX N/A
  • EPS
  • COHU N/A
  • DVAX 0.15
  • Revenue
  • COHU $444,883,000.00
  • DVAX $260,810,000.00
  • Revenue This Year
  • COHU N/A
  • DVAX $23.13
  • Revenue Next Year
  • COHU $23.15
  • DVAX $19.60
  • P/E Ratio
  • COHU N/A
  • DVAX $80.80
  • Revenue Growth
  • COHU N/A
  • DVAX N/A
  • 52 Week Low
  • COHU $22.80
  • DVAX $9.74
  • 52 Week High
  • COHU $36.60
  • DVAX $15.01
  • Technical
  • Relative Strength Index (RSI)
  • COHU 42.55
  • DVAX 52.22
  • Support Level
  • COHU $24.66
  • DVAX $11.61
  • Resistance Level
  • COHU $27.01
  • DVAX $13.74
  • Average True Range (ATR)
  • COHU 1.14
  • DVAX 0.52
  • MACD
  • COHU -0.24
  • DVAX 0.09
  • Stochastic Oscillator
  • COHU 6.93
  • DVAX 32.80

About COHU Cohu Inc.

Cohu Inc is a supplier of semiconductor test and inspection handlers, micro-electro-mechanical system (MEMS) test modules, test contactors, and thermal sub-systems used by semiconductor manufacturers and test subcontractors. The company's products include Semiconductor ATE (Automated Test Equipment), Semiconductor Handlers, Interface Products such as test contactors, probe heads and probe pins, Spares and Kits, Bare Board PCB Test Systems, and services. It has one reportable segment, Semiconductor Test and Inspection Equipment (Semiconductor Test & Inspection).

About DVAX Dynavax Technologies Corporation

Dynavax Technologies Corp is a biopharmaceutical company. The company focuses on leveraging the power of the body's innate and adaptive immune responses through toll-like receptor stimulation. Its current product candidates are being investigated for use in multiple cancer indications as a vaccine for the prevention of HEPLISAV-B (Hepatitis B Vaccine (Recombinant), Adjuvanted), operates in the business segment of discovery, development, and commercialization of novel vaccines. Its Toll-like Receptor Immune Modulation Platform technology plays a vital role in innate immunity and subsequent adaptive immunity. The company generates the vast majority of its revenue from the sale of its CpG 1018 product and HEPLISAV-B.

Share on Social Networks: